Muszbek, N., Proudfoot, C., Fournier, M., Chen, C., Kuznik, A., Kiss, Z., . . . Michaud, K. (2019). Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs. Adv Ther.

Muszbek, Noemi, Clare Proudfoot, Marie Fournier, Chieh-I Chen, Andreas Kuznik, Zsofia Kiss, Peter Gal, et Kaleb Michaud. "Economic Evaluation of Sarilumab in the Treatment of Adult Patients With Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs." Adv Ther 2019.

Muszbek, Noemi, et al. "Economic Evaluation of Sarilumab in the Treatment of Adult Patients With Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs." Adv Ther 2019.